Literature DB >> 16601083

Structural determinants of 4-chloro-m-cresol required for activation of ryanodine receptor type 1.

Alan R Jacobson1, Scott T Moe, P D Allen, James D Fessenden.   

Abstract

4-Chloro-m-cresol (4-CmC) is a clinically relevant activator of the intracellular Ca2+ release channel, the ryanodine receptor isoform 1 (RyR1). In this study, the chemical moieties on the 4-CmC molecule required for its activation of RyR1 were determined using structure-activity relationship analysis with a set of commercially available 4-CmC analogs. Separate compounds each lacking one of the three functional groups of 4-CmC (1-hydroxyl, 3-methyl, or 4-chloro) were poor activators of RyR1. Substitution of different chemical groups for the 1-hydroxyl of 4-CmC resulted in compounds that were poor activators of RyR1, suggesting that the hydroxyl group is preferred at this position. Substitution of hydrophobic groups at the 3-position enhanced bioactivity of the compound relative to 4-CmC, whereas substitution with hydrophilic groups abolished bioactivity. Likewise, 4-CmC analogs with hydrophobic groups substituted into the 4-position enhanced bioactivity, whereas hydrophilic or charged groups diminished bioactivity. 4-CmC analogs containing a single hydrophobic group at either the 3- or 4-position as well as 3,5-disubstituted or 3,4,5-trisubstituted phenols were also effective activators of RyR1. These results indicate that the 1-hydroxyl group of 4-CmC is required for activation of RyR1 and that hydrophobic groups at the 3,4- and 5-positions are preferred. These findings suggest that the 4-CmC binding site on RyR1 most likely consists of a hydrophilic region to interact with the 1-hydroxyl as well as a hydrophobic region(s) to interact with chemical groups at the 3- and/or 4-positions of 4-CmC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16601083     DOI: 10.1124/mol.106.022491

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  7 in total

1.  Green tea catechins are potent sensitizers of ryanodine receptor type 1 (RyR1).

Authors:  Wei Feng; Gennady Cherednichenko; Chris W Ward; Isela T Padilla; Elaine Cabrales; José R Lopez; José M Eltit; Paul D Allen; Isaac N Pessah
Journal:  Biochem Pharmacol       Date:  2010-05-22       Impact factor: 5.858

2.  Designing calcium release channel inhibitors with enhanced electron donor properties: stabilizing the closed state of ryanodine receptor type 1.

Authors:  Yanping Ye; Daniel Yaeger; Laura J Owen; Jorge O Escobedo; Jialu Wang; Jeffrey D Singer; Robert M Strongin; Jonathan J Abramson
Journal:  Mol Pharmacol       Date:  2011-10-11       Impact factor: 4.436

3.  Characterization of ryanodine receptor type 1 single channel activity using "on-nucleus" patch clamp.

Authors:  Larry E Wagner; Linda A Groom; Robert T Dirksen; David I Yule
Journal:  Cell Calcium       Date:  2014-06-06       Impact factor: 6.817

4.  The ryanodine receptor agonist 4-chloro-3-ethylphenol blocks ORAI store-operated channels.

Authors:  Bo Zeng; Gui-Lan Chen; Nikoleta Daskoulidou; Shang-Zhong Xu
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

5.  Functional validation and expression analysis of myotubes converted from skin fibroblasts using a simple direct reprogramming strategy.

Authors:  Fukuko Horio; Hidetoshi Sakurai; Yutaka Ohsawa; Shiho Nakano; Makoto Matsukura; Isao Fujii
Journal:  eNeurologicalSci       Date:  2016-11-03

6.  TNF Induces Pathogenic Programmed Macrophage Necrosis in Tuberculosis through a Mitochondrial-Lysosomal-Endoplasmic Reticulum Circuit.

Authors:  Francisco J Roca; Laura J Whitworth; Sarah Redmond; Ana A Jones; Lalita Ramakrishnan
Journal:  Cell       Date:  2019-08-29       Impact factor: 41.582

Review 7.  Finding possible pharmacological effects of identified organic compounds in medicinal waters (BTEX and phenolic compounds).

Authors:  István Szabó; Csaba Varga
Journal:  Int J Biometeorol       Date:  2019-10-31       Impact factor: 3.787

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.